Abstract:Aim:
Comparison of the integral dose (ID) delivered to organs at risk (OAR), non-target body and target body by using different techniques of craniospinal irradiation (CSI).
Materials and methods:
Ten CSI patients (medulloblastoma) already planned and treated either with linear accelerator three-dimensional conformal radiation therapy (Linac-3DCRT) technique or with linear accelerator RapidArc (Linac-RapidArc) technique by Novalis-Tx Linac machine have been analysed. Retrospectively, the… Show more
“…The S cp , S cp , D f %, and đ« S cp were calculated from Equations ( 3), ( 5), (6), and (7) F I G U R E 5 S cp difference D f % between the beam energies of 18 MV (L 1 ) and 23 MV (L 2 ), for all studied fields. S cp, scatter factor.…”
Section: Discussionmentioning
confidence: 99%
“…The S cp , S cp , D f %, and đ« S cp were calculated from Equations (3), ( 5), (6), and (7) Also, computerized investigations proved that these differences are small at the IC and large away from it under the same conditions. 3,24,37 In addition, Ian et al 25,26 proved, after correcting the missing tissue in breast, that these differences increase with the decreasing energy of the photon beam.…”
Section: Discussionmentioning
confidence: 99%
“…The S cp , S cp , D f %, and đ« S cp were calculated from Equations (3), ( 5), (6), and (7) 10 Ă 10 cm 2 and also (r) does not exceed 7 cm in most clinical cases, 25,26,38 so the difference is within 1% (Table 5). This also applies to cases of the brain and head & neck radiotherapy.…”
Section: Discussionmentioning
confidence: 99%
“…The uncertainty of the S cp measurements was calculated as the standard deviation (STDEV.P) of the three measurements for the SSF s and SOF s including the respective OAR measurements, and the SD of the four averages of the measurements of the four alternative quadrants for the SHF s and SQF s using Equation (7).…”
Section: S Cp For Ssfs [S Cp (Ic)]mentioning
confidence: 99%
“…TFs are usually described using the notation (y 1 ,y 2 ,x 1 ,x 2 ), where y 1 , y 2 , x 1 and x 2 are the respective collimator jaw positions (in cm) determined at the level of the IC. Asymmetric fields are commonly used in radiotherapy, and regarding treatment planning, there are three special categories of interest (for singleisocenter techniques), according to the location of the IC with respect to the TF: (a) The IC is centered at an edge of the TF, as in the case of the half -beams used in the treatment of breast, 4 as shown in Figure 1a, head and neck, 5 and craniospinal tumors, 6,7 (b) The IC is located at a corner of the TF as in the case of a quarterbeams used for the treatment of the chest wall in breast cancer cases, 4,8 as shown in Figure 1b, c) The IC is outside TF, in special cases like the off -isocenter-beams are used for the treatment of the supraclavicular area and the boost field used for breast tumors, 9 as shown in Figure 1c and d, respectively.…”
ObjectiveMonitor unit (MU) verification for any symmetric or asymmetric field is performed using a total scatter factor (Scp), that is calculated based on the geometric equivalent square field (GESF) concept. In this study, we measured the Scp of various asymmetric square fields (ASFs) and their respective GESFs.MethodsSquare halfâfields (SHFs), square quarterâfields (SQFs) and square offâisocenter fields (SOFs), with sizes ranging from 3Ă3 cm2 to 20Ă20 cm2 were created, by varying the collimator jaws of two Varian iX Linacs (6/18 and 6/23 MV). A semiâflex ion chamber was used to measure Scp at a depth of 10Â cm within a water phantom, at the effective field center (EFC) of all ASFs, and at the isocenter (IC) of their respective GESFs. The later Scp values were corrected by the offâaxis ratio [OAR(r)] of the 40Ă40 cm2 field size, where r is the distance between EFC and IC.ResultsThe results show that the Scp (EFC) is independent of the type of the ASF (SHF, SQF, or SOF) and no significant difference exists between the 18 and 23 MV beams. Compared with the Scp (IC), the Scp (EFC) increased with increasing r, by up to 2% and 4% for 18/23 and 6 MV, respectively.ConclusionsThe GESF concept provides acceptable accuracy (<Â 2%) for the calculation of Scp of the ASFs used in most clinical situations (except from SOF with EFC at large r), and thus can be used in MU verification calculations.
“…The S cp , S cp , D f %, and đ« S cp were calculated from Equations ( 3), ( 5), (6), and (7) F I G U R E 5 S cp difference D f % between the beam energies of 18 MV (L 1 ) and 23 MV (L 2 ), for all studied fields. S cp, scatter factor.…”
Section: Discussionmentioning
confidence: 99%
“…The S cp , S cp , D f %, and đ« S cp were calculated from Equations (3), ( 5), (6), and (7) Also, computerized investigations proved that these differences are small at the IC and large away from it under the same conditions. 3,24,37 In addition, Ian et al 25,26 proved, after correcting the missing tissue in breast, that these differences increase with the decreasing energy of the photon beam.…”
Section: Discussionmentioning
confidence: 99%
“…The S cp , S cp , D f %, and đ« S cp were calculated from Equations (3), ( 5), (6), and (7) 10 Ă 10 cm 2 and also (r) does not exceed 7 cm in most clinical cases, 25,26,38 so the difference is within 1% (Table 5). This also applies to cases of the brain and head & neck radiotherapy.…”
Section: Discussionmentioning
confidence: 99%
“…The uncertainty of the S cp measurements was calculated as the standard deviation (STDEV.P) of the three measurements for the SSF s and SOF s including the respective OAR measurements, and the SD of the four averages of the measurements of the four alternative quadrants for the SHF s and SQF s using Equation (7).…”
Section: S Cp For Ssfs [S Cp (Ic)]mentioning
confidence: 99%
“…TFs are usually described using the notation (y 1 ,y 2 ,x 1 ,x 2 ), where y 1 , y 2 , x 1 and x 2 are the respective collimator jaw positions (in cm) determined at the level of the IC. Asymmetric fields are commonly used in radiotherapy, and regarding treatment planning, there are three special categories of interest (for singleisocenter techniques), according to the location of the IC with respect to the TF: (a) The IC is centered at an edge of the TF, as in the case of the half -beams used in the treatment of breast, 4 as shown in Figure 1a, head and neck, 5 and craniospinal tumors, 6,7 (b) The IC is located at a corner of the TF as in the case of a quarterbeams used for the treatment of the chest wall in breast cancer cases, 4,8 as shown in Figure 1b, c) The IC is outside TF, in special cases like the off -isocenter-beams are used for the treatment of the supraclavicular area and the boost field used for breast tumors, 9 as shown in Figure 1c and d, respectively.…”
ObjectiveMonitor unit (MU) verification for any symmetric or asymmetric field is performed using a total scatter factor (Scp), that is calculated based on the geometric equivalent square field (GESF) concept. In this study, we measured the Scp of various asymmetric square fields (ASFs) and their respective GESFs.MethodsSquare halfâfields (SHFs), square quarterâfields (SQFs) and square offâisocenter fields (SOFs), with sizes ranging from 3Ă3 cm2 to 20Ă20 cm2 were created, by varying the collimator jaws of two Varian iX Linacs (6/18 and 6/23 MV). A semiâflex ion chamber was used to measure Scp at a depth of 10Â cm within a water phantom, at the effective field center (EFC) of all ASFs, and at the isocenter (IC) of their respective GESFs. The later Scp values were corrected by the offâaxis ratio [OAR(r)] of the 40Ă40 cm2 field size, where r is the distance between EFC and IC.ResultsThe results show that the Scp (EFC) is independent of the type of the ASF (SHF, SQF, or SOF) and no significant difference exists between the 18 and 23 MV beams. Compared with the Scp (IC), the Scp (EFC) increased with increasing r, by up to 2% and 4% for 18/23 and 6 MV, respectively.ConclusionsThe GESF concept provides acceptable accuracy (<Â 2%) for the calculation of Scp of the ASFs used in most clinical situations (except from SOF with EFC at large r), and thus can be used in MU verification calculations.
Background
Total lymphoid irradiation (TLI) is a conditioning regimen in allogeneic hematopoietic stem cell transplantation (allo-HSCT) which may reduce long-term toxicities attributed to other techniques, such as total body irradiation (TBI). At our institution, TLI treatments were first planned with the three-dimensional conformal radiation therapy (3D-CRT) technique and later with volumetric modulated arc therapy (VMAT). With the recent availability of a basic helical tomotherapy (HT), the possible dosimetric gain of the latter for TLI is studied.
Materials and methods
22 pediatric patients were planned for VMAT and HT, prescribed to 8 Gy in 4 fractions. VMAT was planned with template based on a single cost function, using the Monaco treatment planning system (TPS). HT plans were planned using Accuray Precision TPS for a basic HT without the dynamic jaws feature or VOLO-Ultra algorithm. Plan quality was analyzed based on four quality indices, mean and maximum doses to planning target volume (PTV) and organs at risk (OARs), dose gradient and integral doses. Differences were analyzed with Wilcoxon signed-rank test.
Results
HT plans resulted in improved conformity (CI) and homogeneity indices (HI) (p < 0.05) but less steep dose gradient (p = 0.181). VMAT plans created larger areas with high doses within the PTV, while comparable doses to OARs, except mainly for the spinal marrow, for which a reduction of 37.7% in D
2%
was obtained (p < 0.05). Integral dose for non-tumor tissue was 11.3% lower with the VMAT template (p < 0.05).
Conclusion
HT achieves better conformity and homogeneity even without its more advanced features. Nevertheless, the VMAT template achieves dosimetric results close to those of HT, both with similar clinical outcome.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citationsâcitations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.